Medical News Today, 04 Apr 2011
Young adult patients with genetic heart diseases, such as hypertrophic cardiomyopathy (HCM), substantially benefitted from therapeutic hypothermia, which could further extend the role for this treatment strategy in new patient populations. read more....
(Source: Minneapolis Heart Institute Foundation)
Monday, April 4, 2011
Subscribe to:
Posts (Atom)
